1-2 of 2
James A. Connelly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

Ashley V. Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, James A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S. Kean, K. Scott Baker, Lauri M. Burroughs, Jeffrey R. Andolina, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Julie-An Talano, Kirk R. Schultz, Elizabeth O. Stenger, Howard Lin, Adi Zoref-Lorenz, Kenneth L. McClain, Michael B. Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3725–3734.
https://doi.org/10.1182/bloodadvances.2022009478
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor

Clinical Trials & Observations
David C. Dale, Audrey Anna Bolyard, James A. Shannon, IV, James A. Connelly, Daniel C. Link, Mary Ann Bonilla, Peter E. Newburger
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3861–3869.
https://doi.org/10.1182/bloodadvances.2021005684
Published: 2022
Includes: Supplemental data